Wound care device developer Integrated Healing Technologies raised $2 million in a new round of equity financing, according to an SEC filing posted today.
Integrated Healing Technologies is developing negative pressure wound therapy devices for treating difficult to heal, or chronic, wounds. The company’s system works through removing biofilm, binding and removing pathogens from the wound site and removing exudate by applying negative pressure, according to its site.
Current products from the company include the New Era I and New Era II negative pressure wound therapy pumps designed to deliver negative pressure and remove fluids from chronic, non-healing wounds.
The company also produces PhaseOne hypochlorous solution, which acts as an antimicrobial agent, and the Cutimed Sorbact wound filler.
The money comes from 42 anonymous investors, according to the SEC filing, with the company looking to pull in another $2 million before closing the round. Integrated Healing Technologies has not yet stated how it plans to spend funds raised in the round.
